Table 1.

Frequency of the most common deleteriously mutated genes in familial pancreatic cancer

Gene	Zhen et al 44 (n=515)	Roberts et al 22 (n=166)	Takai et al 45 (n=54)	Mutation prevalence (%)
BRCA2	19	n.a.	3	3.9
ATM	n.a.	4	2	2.7
CDKN2A	13	n.a.	n.a.	2.5
BRCA1	6	n.a.	n.a.	1.2
PALB2	3	n.a.	2	0.9

Mutations data were analysed from three familial pancreatic cancer cohorts (735 samples).

n.a., not applicable.